Home/Filings/4/0001193805-10-000276
4//SEC Filing

Camut Christopher C 4

Accession 0001193805-10-000276

CIK 0001326190other

Filed

Jan 28, 7:00 PM ET

Accepted

Jan 29, 2:55 PM ET

Size

5.3 KB

Accession

0001193805-10-000276

Insider Transaction Report

Form 4
Period: 2010-01-21
Camut Christopher C
VP, Chief Financial Officer
Transactions
  • Tax Payment

    Common Stock, $0.0001 par value per share

    2010-01-21$1.73/sh2,531$4,37946,777 total
Footnotes (1)
  • [F1]Shares withheld at vesting of restricted stock for purposes of meeting the Reporting Person's tax obligations. The closing price of the issuer's common stock on the NYSE Amex on 1/21/2010 was $1.73.

Issuer

PHARMATHENE, INC

CIK 0001326190

Entity typeother

Related Parties

1
  • filerCIK 0001409861

Filing Metadata

Form type
4
Filed
Jan 28, 7:00 PM ET
Accepted
Jan 29, 2:55 PM ET
Size
5.3 KB